6857.TWO Acer Medical Inc.
- Market cap
- TWD 1.41B
- P/E
- -
- P/B
- 9.09x
- ROE
- -18.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6857.TWO undervalued?
Graham numberThe Graham number of Acer Medical Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Acer Medical Inc. fundamental analysis
No fundamental analysis for Acer Medical Inc. yet.
Acer Medical Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Acer Medical Inc.
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also pr…
Full company profileAcer Medical Inc. financial statements
Acer Medical Inc. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | 1.01M | 9.63M | 13.1M | 27.4M | 50.2M | 60.1M |
| Gross Profit | - | 343K | 6.44M | 6.14M | 12.9M | 31.7M | 37.5M |
| Operating Income | - | -12.0M | -20.4M | -55.2M | -41.2M | -30.2M | -32.7M |
| EBITDA | -5.53M | -11.8M | -20.4M | -54.5M | -39.9M | -29.0M | -28.4M |
| Net Income | -5.63M | -11.9M | -20.4M | -54.7M | -38.2M | -27.4M | -29.7M |
| EPS | -1.08 | -2.29 | -2.64 | -4.43 | -2.51 | -1.80 | -1.95 |
| Balance Sheet | |||||||
| Total Assets | - | 43.5M | 137M | 290M | 259M | 227M | 207M |
| Total Liabilities | 89.0K | 14.3M | 21.9M | 30.0M | 37.5M | 32.3M | 42.3M |
| Shareholders' Equity | - | 29.2M | 115M | 260M | 222M | 195M | 165M |
| Cash & Short-term Investments | -89.0K | 43.4M | 130M | 277M | 220M | 203M | 176M |
| Total Debt | 89.0K | - | - | - | 4.00K | 85.0K | - |
| Cash Flow | |||||||
| Operating Cash Flow | -2.79M | -3.61M | -18.8M | -45.8M | -53.1M | -20.7M | -24.6M |
| Capital Expenditure | 0.00 | 0.00 | 865K | 7.41M | 762K | 0.00 | 1.08M |
| Free Cash Flow | -2.79M | -3.61M | -19.7M | -53.2M | -53.9M | -20.7M | -25.7M |
| Ratios | |||||||
| ROE | - | -40.8% | -17.8% | -21.0% | -17.2% | -14.1% | -18.0% |
| ROA | - | -27.4% | -15.0% | -18.9% | -14.7% | -12.1% | -14.3% |
| Net Profit Margin | - | -1,176.0% | -212.4% | -418.9% | -139.1% | -54.6% | -49.4% |
| Debt to Equity | - | - | - | - | 0.00x | 0.00x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Acer Medical Inc. dividends
Acer Medical Inc. has not paid dividends in the last 7 fiscal years.
Who owns Acer Medical Inc.
Ownership data of Acer Medical Inc. is not available yet.
Acer Medical Inc. company profile
- Company name
- Acer Medical Inc.
- Ticker
- 6857.TWO
- ISIN
- TW0006857006
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Health Information Services
- Fiscal year end
- December
- Address
- No. 88, Section 1, Xintai 5th Road, New Taipei City, Taiwan
- Phone
- 886 2 2696 0366
- Website
- acer-medical.com
About Acer Medical Inc.
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also provides aiMed, a generative AI platform for healthcare environments; aiGait, balance and gait assessment software; non-mydriatic automated portable fundus camera; and portable X-ray system solutions. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
Acer Medical Inc. management
2- Mr. Ming Yuan ChenFinance & Accounting Manager
- Mr. Yong Xin LiChief Operating Officer